Overview
WST market data
Price History
WST price chart · 1M
- O
- 365.59
- H
- 366.76
- L
- 361.53
- C
- 362.41
- Vol
- 35,116.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $365.59
- Previous Close
- $364.70
- Day High
- $366.76
- Day Low
- $361.53
- 52 Week High
- $382.87
- 52 Week Low
- $299.52
- 7 Day Return
- +7.34%
- 30 Day Return
- +4.52%
- 90 Day Return
- +10.58%
- 1 Year Return
- +19.12%
- Daily Notional Volume
- $12.7M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 43.13 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.79 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.15 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.3% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 17.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $223.83 – $386.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $24.4B · P/B 6.23 · P/S 7.32.
Company News
10 captured
Here's Why You Should Add BrightSpring Stock to Your Portfolio NowZacks Investment Research ·
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock DownZacks Investment Research ·
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA ClearanceZacks Investment Research ·
The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?Zacks Investment Research ·
Here's Why You Should Retain AMN Stock in Your Portfolio for NowZacks Investment Research ·
Philips Expands Women's Health Ultrasound Portfolio With New TransducerZacks Investment Research ·
Here's Why You Should Retain Cencora Stock in Your Portfolio for NowZacks Investment Research ·
TXG Stock Down Despite Patent Verdict Win Against Parse BiosciencesZacks Investment Research ·
Veeva Systems Q2 Earnings and Revenues Beat Estimates, Stock UpZacks Investment Research ·